OVERVIEW

Hypertension Guidelines Update: Where Are We Now? is organized by Southern Medical Association (SMA) and will be held from Sep 04, 2018 - Sep 04, 2019. This Conference has been approved for a maximum of 1 AMA PRA Category 1 Credits™.

Target Audience :
This activity is intended for physicians, physician assistants, nurse practitioners, registered nurses, and other allied healthcare professionals specializing or certified in the areas of women’s health, gynecology, obstetrics, internal medicine, family or general medicine, geriatric medicine, emergency medicine, and preventive medicine.

Goals and Objectives :
Despite safe and effective non-pharmacologic and pharmacologic treatment for hypertension, the cardiovascular disease burden attributed to partially or untreated hypertension continues to be a major public health crisis. To address this disease burden in the United States, and now globally, hypertension guidelines have been periodically developed to aid in the clinical diagnosis, management, and treatment of the individual with hypertension. Recently in 2018, the American College of Cardiology and the American Heart Association (ACC-AHA) released new hypertension guidelines. These guidelines differed greatly from previous guidelines in the United States as well as other countries. Importantly, the guidelines re-classified the blood pressure levels that lead to the diagnosis of hypertension, lower both treatment blood pressure thresholds and blood pressure goal levels, address the importance of properly performed blood pressure measurements in the office as well as the importance of out-of-office blood pressure determinations, and detail a "team-based" clinical approach to the individual with hypertension. Given the magnitude of the changes in these guidelines, there is a need to review these guidelines and the evidence-based medicine that led to the changes proposed and to determine the clinical applicability of the guidelines. Upon completion of the activity, providers should be able to:

• Compare and contrast the recommendations of the ACC-AHA 2018 Hypertension Guidelines to those previously published;
• Interpret the important new clinical studies and their results which led to the changes proposed in the ACC-AHA 2018 guidelines;
• Determine the clinical importance and applicability of the ACC-AHA 2018 Hypertension Guidelines to the practicing clinician in the management and treatment of hypertension.

Credits will be archived for 6 years

Additional details will be posted as soon as they are available.

SPECIALITIES

Renal Medicine Disease and Hypertension